The current management of type 1 diabetes mellitus (T1DM) involves the use of intensive insulin therapy—either by insulin pump therapy or multiple daily injection (MDI) therapy—and carbohydrate counting [1]. This evidence concerns the gene INS and type 1 diabetes mellitus.